412 related articles for article (PubMed ID: 16497488)
1. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
3. Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia.
Smesny S; Rosburg T; Nenadic I; Fenk KP; Kunstmann S; Rzanny R; Volz HP; Sauer H
Neuroimage; 2007 Apr; 35(2):729-37. PubMed ID: 17276699
[TBL] [Abstract][Full Text] [Related]
4. Association between cortical metabolite levels and clinical manifestations of migrainous aura: an MR-spectroscopy study.
Schulz UG; Blamire AM; Corkill RG; Davies P; Styles P; Rothwell PM
Brain; 2007 Dec; 130(Pt 12):3102-10. PubMed ID: 17956910
[TBL] [Abstract][Full Text] [Related]
5. Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging.
Jensen JE; Frederick Bde B; Renshaw PF
NMR Biomed; 2005 Dec; 18(8):570-6. PubMed ID: 16273508
[TBL] [Abstract][Full Text] [Related]
6. Grey matter deficits and symptom profile in first episode schizophrenia.
Whitford TJ; Farrow TF; Gomes L; Brennan J; Harris AW; Williams LM
Psychiatry Res; 2005 Aug; 139(3):229-38. PubMed ID: 16055311
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
Szulc A; Galińska B; Tarasów E; Walecki J; Dzienis W; Kubas B; Czernikiewicz A
Psychiatr Pol; 2003; 37(6):977-88. PubMed ID: 14727370
[TBL] [Abstract][Full Text] [Related]
8. Frontal lobe volumes in schizophrenia: effects of stage and duration of illness.
Premkumar P; Kumari V; Corr PJ; Sharma T
J Psychiatr Res; 2006 Oct; 40(7):627-37. PubMed ID: 16901506
[TBL] [Abstract][Full Text] [Related]
9. Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia.
Okugawa G; Sedvall GC; Agartz I
Eur Arch Psychiatry Clin Neurosci; 2002 Jun; 252(3):120-3. PubMed ID: 12192469
[TBL] [Abstract][Full Text] [Related]
10. A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia.
Riffkin J; Yücel M; Maruff P; Wood SJ; Soulsby B; Olver J; Kyrios M; Velakoulis D; Pantelis C
Psychiatry Res; 2005 Feb; 138(2):99-113. PubMed ID: 15766634
[TBL] [Abstract][Full Text] [Related]
11. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
[TBL] [Abstract][Full Text] [Related]
12. [Magnetic resonance spectroscopy in schizophrenia].
Delamillieure P; Constans JM; Fernandez J; Dollfus S
Encephale; 2000; 26(1):21-31. PubMed ID: 10875059
[TBL] [Abstract][Full Text] [Related]
13. Brain structural differences associated with the behavioural phenotype in children with Williams syndrome.
Campbell LE; Daly E; Toal F; Stevens A; Azuma R; Karmiloff-Smith A; Murphy DG; Murphy KC
Brain Res; 2009 Mar; 1258():96-107. PubMed ID: 19118537
[TBL] [Abstract][Full Text] [Related]
14. Regional axonal abnormalities in first episode schizophrenia: preliminary evidence based on high b-value diffusion-weighted imaging.
Mendelsohn A; Strous RD; Bleich M; Assaf Y; Hendler T
Psychiatry Res; 2006 Apr; 146(3):223-9. PubMed ID: 16527464
[TBL] [Abstract][Full Text] [Related]
15. High-energy phosphate metabolism in the frontal lobes of patients with panic disorder detected by phase-encoded 31P-MRS.
Shioiri T; Kato T; Murashita J; Hamakawa H; Inubushi T; Takahashi S
Biol Psychiatry; 1996 Oct; 40(8):785-93. PubMed ID: 8894072
[TBL] [Abstract][Full Text] [Related]
16. Duration of untreated psychosis and proton magnetic resonance spectroscopy (1H-MRS) findings in first-episode schizophrenia.
Galińska B; Szulc A; Tarasów E; Kubas B; Dzienis W; Czernikiewicz A; Walecki J
Med Sci Monit; 2009 Feb; 15(2):CR82-88. PubMed ID: 19179972
[TBL] [Abstract][Full Text] [Related]
17. Investigating the neuropsychological and neuroanatomical changes that occur over the first 2-3 years of illness in patients with first-episode schizophrenia.
Zipparo L; Whitford TJ; Redoblado Hodge MA; Lucas S; Farrow TF; Brennan J; Gomes L; Williams LM; Harris AW
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):531-8. PubMed ID: 18061326
[TBL] [Abstract][Full Text] [Related]
18. Prefrontal but not temporal grey matter changes in males with first-episode schizophrenia.
Kaspárek T; Prikryl R; Mikl M; Schwarz D; Cesková E; Krupa P
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):151-7. PubMed ID: 17011096
[TBL] [Abstract][Full Text] [Related]
19. A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia.
Cheung V; Cheung C; McAlonan GM; Deng Y; Wong JG; Yip L; Tai KS; Khong PL; Sham P; Chua SE
Psychol Med; 2008 Jun; 38(6):877-85. PubMed ID: 17949516
[TBL] [Abstract][Full Text] [Related]
20. Association between a longer duration of illness, age and lower frontal lobe grey matter volume in schizophrenia.
Premkumar P; Fannon D; Kuipers E; Cooke MA; Simmons A; Kumari V
Behav Brain Res; 2008 Nov; 193(1):132-9. PubMed ID: 18586335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
